Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Naganuma

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
The Journal of Investigative Dermatology|October 9, 1998
Novel function of metallothionein in photoprotection: metallothionein-null mouse exhibits reduced tolerance against ultraviolet B injury in the skinK Hanada, D Sawamura, K Tamai, et al.
Cancer Research|April 15, 1993
Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesisM Satoh, D M Kloth, S A Kadhim, et al.
Japanese Journal of Cancer Research : Gann|April 1, 2000
HeLa cell transformants overproducing mouse metallothionein show in vivo resistance to cis-platinum in nude miceH Toyoda, T Mizushima, M Satoh, et al.
Virus Research|February 2, 2000
Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cellsM Ikeda, A Nozaki, K Sugiyama, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|February 24, 2001
[A case of acute respiratory distress syndrome induced by fulminant influenza A (H3 N2) pneumonia]A Naganuma, H Mizuma, I Doi, et al.
Anticancer Research|January 11, 2000
Establishment and characterization of a cisplatin-resistant human neuroblastoma cell lineT Yasuno, T Matsumura, T Shikata, et al.
Acta Gastro-Enterologica Belgica|February 28, 2021
A change in the timing for starting systemic therapies for hepatocellular carcinoma: the comparison of sorafenib and lenvatinib as the first-line treatmentT Hatanaka, S Kakizaki, T Nagashima, et al.
Acta Gastro-Enterologica Belgica|December 25, 2022
Prognosis and incidence of immunological and oncological complications after direct-acting antiviral therapy for chronic hepatitis CY Kanayama, K Sato, S Saito, et al.
Acta Gastro-Enterologica Belgica|February 28, 2021
Tolvaptan reduces the required amount of albumin infusion in patients with decompensated cirrhosis with uncontrolled ascites : a multicenter retrospective propensity score-matched cohort studyY Suzuki, A Naganuma, T Hoshino, et al.
ESMO Open|October 8, 2022
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysisM Rimini, L Rimassa, K Ueshima, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
The Journal of Investigative Dermatology|October 9, 1998
Novel function of metallothionein in photoprotection: metallothionein-null mouse exhibits reduced tolerance against ultraviolet B injury in the skinK Hanada, D Sawamura, K Tamai, et al.
Cancer Research|April 15, 1993
Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesisM Satoh, D M Kloth, S A Kadhim, et al.
Japanese Journal of Cancer Research : Gann|April 1, 2000
HeLa cell transformants overproducing mouse metallothionein show in vivo resistance to cis-platinum in nude miceH Toyoda, T Mizushima, M Satoh, et al.
Virus Research|February 2, 2000
Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cellsM Ikeda, A Nozaki, K Sugiyama, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|February 24, 2001
[A case of acute respiratory distress syndrome induced by fulminant influenza A (H3 N2) pneumonia]A Naganuma, H Mizuma, I Doi, et al.
Anticancer Research|January 11, 2000
Establishment and characterization of a cisplatin-resistant human neuroblastoma cell lineT Yasuno, T Matsumura, T Shikata, et al.
Acta Gastro-Enterologica Belgica|February 28, 2021
A change in the timing for starting systemic therapies for hepatocellular carcinoma: the comparison of sorafenib and lenvatinib as the first-line treatmentT Hatanaka, S Kakizaki, T Nagashima, et al.
Acta Gastro-Enterologica Belgica|December 25, 2022
Prognosis and incidence of immunological and oncological complications after direct-acting antiviral therapy for chronic hepatitis CY Kanayama, K Sato, S Saito, et al.
Acta Gastro-Enterologica Belgica|February 28, 2021
Tolvaptan reduces the required amount of albumin infusion in patients with decompensated cirrhosis with uncontrolled ascites : a multicenter retrospective propensity score-matched cohort studyY Suzuki, A Naganuma, T Hoshino, et al.
ESMO Open|October 8, 2022
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysisM Rimini, L Rimassa, K Ueshima, et al.
Pageof 9